These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17039492)

  • 21. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.
    Dooms C; Verbeken E; Stroobants S; Nackaerts K; De Leyn P; Vansteenkiste J
    J Clin Oncol; 2008 Mar; 26(7):1128-34. PubMed ID: 18309948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
    Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
    Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of lymph node metastases in NSCLC. Three dimensional anatomical parameters do not substitute FDG-PET-CT.
    Beyer F; Buerke B; Gerss J; Scheffe K; Puesken M; Weckesser M; Schober O; Heindel W; Wessling J
    Nuklearmedizin; 2010; 49(1):41-8; quiz N1. PubMed ID: 20087533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node staging in lung cancer using [18F]FDG-PET.
    Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
    Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
    Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
    Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.
    Akhurst T
    J Surg Oncol; 2006 Dec; 94(7):547-8. PubMed ID: 17111390
    [No Abstract]   [Full Text] [Related]  

  • 27. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
    Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE
    Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer.
    Nishiyama Y; Yamamoto Y; Kimura N; Ishikawa S; Sasakawa Y; Ohkawa M
    Ann Nucl Med; 2008 May; 22(4):245-50. PubMed ID: 18535874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
    Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.
    Pozo-Rodríguez F; Martín de Nicolás JL; Sánchez-Nistal MA; Maldonado A; García de Barajas S; Calero-García R; Pozo MA; Martín-Escribano P; Martín-García I; García-Lujan R; Lopez-Encuentra A; Arenas de Pablo A
    J Clin Oncol; 2005 Nov; 23(33):8348-56. PubMed ID: 16219937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
    Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
    Shen G; Hu S; Deng H; Jia Z
    Acta Radiol; 2015 Jun; 56(6):681-7. PubMed ID: 24917609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
    Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W
    Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.
    Kang WJ; Chung JK; So Y; Jeong JM; Lee DS; Lee MC
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):202-7. PubMed ID: 15129702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
    de Langen AJ; Raijmakers P; Riphagen I; Paul MA; Hoekstra OS
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):26-9. PubMed ID: 16337397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
    Yuan SH; Yu JM; Yu YH; Fu Z; Guo HB; Liu TH; Yang XH; Yang GR; Li WW
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):221-4. PubMed ID: 17649642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
    Kubota K; Murakami K; Inoue T; Itoh H; Saga T; Shiomi S; Hatazawa J
    Ann Nucl Med; 2011 Dec; 25(10):777-86. PubMed ID: 21901365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioguided detection of lymph node metastasis in non-small cell lung cancer.
    Nwogu C; Fischer G; Tan D; Glinianski M; Lamonica D; Demmy T
    Ann Thorac Surg; 2006 Nov; 82(5):1815-20; discussion 1820. PubMed ID: 17062254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening-detected lung cancers: is systematic nodal dissection always essential?
    Veronesi G; Maisonneuve P; Pelosi G; Casiraghi M; Agoglia BG; Borri A; Travaini LL; Bellomi M; Rampinelli C; Brambilla D; Bertolotti R; Spaggiari L
    J Thorac Oncol; 2011 Mar; 6(3):525-30. PubMed ID: 21289523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.